Yes I think green on a day of carnage is a pretty good result. If it gets preliminary IV results that are good maybe along with further indication that burns data is still doing same great work then hard to believe it can stay at current levels. It would be interesting to hear an update on their plans for burns treatment commercialisation following the apparent stunning results to date there. I wonder what the yimeframe is for phase 3. Maybe finally Stanley are so impressed with phase 2 they will push for next phase asap due to unmet need? Right now it seems to be just testing support around $1 and if all goes well 1.30 will be the first target then very soon blue sky? Looks like you may be rewarded for your confidence very soon BP.
